Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Mesothelioma 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1

Interventions

Cisplatin 8 Carboplatin 8 Bevacizumab 8 Pleurodesis 7 Talc 6 Paclitaxel 6 Docetaxel 5 Povidone-Iodine 4 Doxycycline 4 Thoracoscopy 3 Taxes 3 Gemcitabine 3 Drug Therapy 3 Chest Tubes 3 aldesleukin 2 Zoledronic Acid 2 Trastuzumab 2 Thoracentesis 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Pharmaceutical Preparations 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 High-Energy Shock Waves 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Cetuximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × tocilizumab × Thoracic × Clear all

NCT06016179 2025-05-22

RIOT2

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡